MedPath

Olfactory Function Following Endoscopic Endonasal Skull Base Surgery

Not Applicable
Conditions
Skull Base Pathology
Registration Number
NCT02165969
Lead Sponsor
Ricardo L. Carrau, MD
Brief Summary

The purpose of this study is to compare a subject's sense of smell before and after endoscopic endonasal surgery to remove a skull base abnormality (i.e. tumor, inflammatory process, fracture, defect, etc.) and use the information collected to validate approaches to surgery that will minimize side effects to the sense of smell function. Data will be collected using a smell identification test along with two questionnaires. In addition, demographic, medical history, treatment, outcome, and follow-up information will be collected.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
160
Inclusion Criteria
  • Patients presenting with skull base pathologies requiring endonasal surgery at The Ohio State University Wexner Medical Center
  • 18 years or older
  • Able to consent for self
  • Negative serum pregnancy test for women of childbearing potential
Exclusion Criteria
  • Patient unable to return to clinic at specific follow-up times
  • Pregnant or nursing
  • Prisoners

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Number of patients with decreased olfactory function after endoscopic endonasal surgeryup to 12 months post surgery

The subject will complete 2 questionnaires and the University of Pennsylvania Smell Identification Test (UPSIT) at baseline (pre-surgery) and at 1, 3, 6, and 12, months post surgery to determine if the sense of smell has been altered from surgery.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

The Ohio State University

🇺🇸

Columbus, Ohio, United States

The Ohio State University
🇺🇸Columbus, Ohio, United States
Amanda McGill, MS
Contact
614-685-8622
Amanda.McGill@osumc.edu
Ricardo Carrau, MD
Principal Investigator

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.